Geneva, April 20 -- International Clinical Trials Registry received information related to the study (NCT07517445) titled 'Bactericidal Activity and Safety of Nicotinamide in Combination With Bedaquiline, Pretomanid, and Linezolid in Drug-susceptible Pulmonary Tuberculosis' on April 1.

Study Type: Interventional

Study Design: Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: None (Open Label).

Primary Sponsor: Gates Medical Research Institute

Condition: Drug Susceptible Pulmonary Tuberculosis

Intervention: Drug: Bedaquiline, pretomanid, linezolid Drug: Bedaquiline, pretomanid, linezolid Drug: Bedaquiline, pretomanid, linezolid

Recruitment Status: Not recruiting

Phase: Phase 2 ...